Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive Multifocal Leukoencephalopathy.

Anna R. Thorner1, Joel T. Katz

  • 1Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. athorner@partners.org, jkatz@partners.org

Current Infectious Disease Reports
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Progressive multifocal leukoencephalopathy (PML) is a serious brain disease caused by JC virus (JCV) reactivation in immunocompromised individuals. While historically fatal, highly active antiretroviral therapy has improved survival for AIDS patients with PML.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease affecting individuals with compromised cell-mediated immunity.
  • It results from the reactivation of the ubiquitous JC virus (JCV), which typically remains latent in healthy adults.
  • JCV infection targets oligodendrocytes and astrocytes, leading to demyelination and necrosis in the brain's white matter.

Purpose of the Study:

  • To describe the pathogenesis, diagnosis, and prognosis of progressive multifocal leukoencephalopathy (PML).
  • To highlight the role of JC virus (JCV) in PML development.
  • To discuss the impact of modern therapies on PML patient outcomes.

Main Methods:

  • Review of existing literature on PML, JC virus (JCV), and associated conditions.

Related Experiment Videos

  • Discussion of diagnostic techniques, including polymerase chain reaction (PCR) for JCV detection.
  • Analysis of treatment strategies and their impact on patient survival.

    • Main Results:

    • JC virus (JCV) infects a large majority of the adult population but is usually latent.
    • PML causes focal neurologic deficits due to demyelination and necrosis, with characteristic MRI findings.
    • Polymerase chain reaction (PCR) is a sensitive diagnostic tool for JCV, often replacing brain biopsy.
    • Historically, PML has a poor prognosis, with a median survival of 6 months.
    • Highly active antiretroviral therapy (HAART) has significantly improved survival rates for AIDS patients diagnosed with PML.

    Conclusions:

    • Progressive multifocal leukoencephalopathy (PML) is a severe opportunistic infection caused by JC virus (JCV) reactivation.
    • Early and accurate diagnosis using PCR is crucial for managing PML.
    • While direct antiviral treatments for JCV remain limited, improvements in antiretroviral therapy have enhanced long-term outcomes for affected individuals, particularly those with AIDS.